Enanta Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Enanta Pharmaceuticals patents 112 in total
Status | Patent |
---|---|
Grant | Utility: Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Application | Utility: HEPATITIS B ANTIVIRAL AGENTS Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Isoxazole analogs as FXR agonists and methods of use thereof Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Hepatitis B antiviral agents Filling date: 6 Sep 2025 Issue date: 15 Oct 2019 |
Application | Utility: PROCESSES FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 10 Oct 2019 |
Grant | Utility: Hepatitis B antiviral agents Filling date: 6 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Heteroaryldiazepine derivatives as RSV inhibitors Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Application | Utility: MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Grant | Utility: Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof Filling date: 6 Sep 2025 Issue date: 30 Jul 2019 |
Showing 100 to 112 of 112 patents.